The Non-Malignant Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Thalassemia Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASCAT 2024 | The pathophysiology and geographic distribution of thalassemia
In this interview, Ali Taher, MD, PhD, FRCP, American University of Beirut Medical Center, Beirut, Lebanon, provides a brief overview of the pathophysiology of thalassemia, highlighting that this hemoglobinopathy is now seen in a larger geographic area due to migration. This interview took place at the 19th Annual Scientific Conference of the Academy for Sickle Cell and Thalassaemia (ASCAT 2024) in London, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Consultancy: Novo Nordisk, Bristol-Myers Squibb (Celgene), Vifor, Pharmacosmos, Agios; Research funding: Bristol-Myers Squibb (Celgene), Vifor, Pharmacosmos, Agios.
